Fresh clinical trial activity evaluates a three dimensionally printed hyrax expander against a conventional device for adolescent maxillary expansion, signaling potential shifts in device sourcing and regulatory oversight.
Ain Shams University in Cairo is sponsoring the study and has listed the trial on ClinicalTrials.gov under the record NCT07411092. The study compares a three dimensionally printed hyrax expander with a conventionally fabricated hyrax expander for patients with transverse maxillary deficiency.
Key details from the source indicate the population is adolescents and the intervention arms cover two device types. Recruitment is ongoing as of February 15, 2026.
In this article
What changed in maxillary expansion device options for adolescents?
Study design and device description
The comparison focuses on a three dimensionally printed hyrax expander versus a conventionally fabricated hyrax expander. The aim is to determine whether the digitally produced device can achieve comparable expansion outcomes while maintaining predictable fit and safety profiles. The information comes from a clinical trial listing and sponsor organization.
These devices represent an approach that combines digital design and additive manufacturing with standard orthodontic mechanics. The aim is to evaluate material behavior, fit to the dental arch, and manufacturability in a real patient setting. No trial results are reported in the source text, and data are not yet publicly available regarding effectiveness or adverse events.
What will the trial measure?
Reportedly the trial involves two device arms for adolescents with transverse maxillary deficiency. The exact outcome measures are not disclosed in the provided text, but anticipated endpoints in such studies typically include amount of expansion achieved, timing of expansion, and any device related complications. Regulatory review will rely on standardized reporting of such endpoints and robust risk management documentation.
Who is affected by this trial?
The population described includes adolescents with transverse maxillary deficiency seeking maxillary arch expansion. If the three dimensionally printed device demonstrates comparable performance and safety to the conventional device, providers may consider alternative sourcing options. The trial status signals ongoing data collection and potential future regulatory submissions for a device produced with digital fabrication methods.
From a regulatory vantage point the development highlights the need for traceability of each printed component and rigorous quality controls in the printing process. The sponsor and manufacturers must ensure that suitable verification and validation practices are in place to support any future submissions for market clearance.
What are regulatory implications for a three dimensional printed dental device?
The trial described is a comparative evaluation rather than a product approval in itself. The information generated could contribute to regulatory decisions about device class and necessary performance data under MDR guidelines. Marketing claims must reflect the exploration nature of the study and not imply approval or acceptance of a device.
Regulators will require defined intended use and performance data including mechanical stability, material biocompatibility and consistency of manufacturing. If the three dimensionally printed expander shows promise the sponsor will likely pursue filings that address manufacturing controls, labeling and post market surveillance considerations.
Safety and performance considerations
Safety assessment will hinge on fit reliability, risk of failure and potential for irritation in the oral environment. Additive manufacturing introduces variability in material properties and surface finishing so procedural controls become important. The trial record will contribute to the evidence base for the safety profile of a printed device in a pediatric to adolescent patient population. Clinicians must look for standardized qualification and supplier documentation when considering a printed device in routine care. Data from the study will guide planning for future quality management and regulatory compliance.
What happens next for researchers and regulators?
If results indicate comparable expansion with a favorable safety profile the next steps will involve dissemination of results through peer reviewed channels and regulatory submissions as appropriate. The path to market or use in practice would depend on demonstrated consistent manufacturing capabilities and robust risk management data. A timely update to the sponsor is expected as results become available.
FAQ
- What is a hyrax expander and how does it work in orthodontics?
- What does three dimensionally printed mean in this context?
- What is the status of the Ain Shams University trial?
- Where can I find the trial record for more details?
Conclusion and implications for practice
The trial underscores a regulatory aware approach to evaluating printed orthodontic devices in adolescents. The information to date indicates a comparative evaluation with clear emphasis on safety and manufacturing controls. Decisions about future use will depend on transparent reporting of results and alignment with MDR requirements.
Disclaimer for professionals
This article provides information to professionals and is not legal advice. It reflects the source text and regulatory considerations without endorsing a specific device. Users should consult current regulatory guidance for their jurisdiction.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07411092?term=medical+device